ATE528392T1 - Neues protein und dessen dns - Google Patents

Neues protein und dessen dns

Info

Publication number
ATE528392T1
ATE528392T1 AT00940840T AT00940840T ATE528392T1 AT E528392 T1 ATE528392 T1 AT E528392T1 AT 00940840 T AT00940840 T AT 00940840T AT 00940840 T AT00940840 T AT 00940840T AT E528392 T1 ATE528392 T1 AT E528392T1
Authority
AT
Austria
Prior art keywords
dna
new protein
protein
present
homology
Prior art date
Application number
AT00940840T
Other languages
English (en)
Inventor
Yusuke Nakamura
Hirofumi Arakawa
Hiroshi Tanaka
Original Assignee
Yusuke Nakamura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yusuke Nakamura filed Critical Yusuke Nakamura
Application granted granted Critical
Publication of ATE528392T1 publication Critical patent/ATE528392T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0093—Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00940840T 1999-06-28 2000-06-27 Neues protein und dessen dns ATE528392T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18113199 1999-06-28
JP19239199 1999-07-06
JP2000017770 2000-01-21
PCT/JP2000/004189 WO2001000799A1 (en) 1999-06-28 2000-06-27 Novel protein and dna thereof

Publications (1)

Publication Number Publication Date
ATE528392T1 true ATE528392T1 (de) 2011-10-15

Family

ID=27324959

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940840T ATE528392T1 (de) 1999-06-28 2000-06-27 Neues protein und dessen dns

Country Status (6)

Country Link
US (2) US6682917B1 (de)
EP (1) EP1191096B1 (de)
AT (1) ATE528392T1 (de)
AU (1) AU5569600A (de)
CA (1) CA2372696A1 (de)
WO (1) WO2001000799A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080026093A (ko) * 2005-05-04 2008-03-24 유니버시티 오브 사우스 플로리다 암 환자의 치료 반응을 예측하는 방법
CN101815793A (zh) * 2007-06-15 2010-08-25 南佛罗里达大学 诊断和治疗癌症的方法
EP2214016B1 (de) * 2007-10-26 2014-09-10 Advanced Life Science Institute, Inc. Gegen progastrin freisetzendes peptid gerichteter antikörper und verwendung davon
BRPI1007483B1 (pt) 2009-01-28 2021-11-30 Bio Preventive Medicine Corporation Método de diagnóstico de nefropatia in vitro, método in vitro para o monitoramento de progresso de nefropatia, método in vitro para o monitoramento da eficácia de um tratamento de nefropatia, método in vitro de avaliação de toxicidade renal de um agente e kit para diagnóstico de nefropatia
US12208133B2 (en) * 2018-06-29 2025-01-28 University Of Washington Engineering the RRM2 subunit of ribonucleotide reductase to resist degradation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169024A1 (en) * 1995-02-07 1996-08-08 Toshiaki Saeki Anti-ribonucleotide reductase r2 subunit monoclonal antibody
JPH1014582A (ja) * 1996-07-08 1998-01-20 Toagosei Co Ltd リボヌクレオチドリダクターゼ
US6222029B1 (en) * 1997-08-01 2001-04-24 Genset 5′ ESTs for secreted proteins expressed in brain
US5891621A (en) * 1997-09-24 1999-04-06 Merck & Co., Inc. Metabolic pathway assay
WO2000015799A2 (en) * 1998-09-17 2000-03-23 Incyte Pharmaceuticals, Inc. Rna-associated proteins

Also Published As

Publication number Publication date
WO2001000799A1 (en) 2001-01-04
US20040072253A1 (en) 2004-04-15
WO2001000799A8 (fr) 2001-12-27
CA2372696A1 (en) 2001-01-04
EP1191096A4 (de) 2004-06-02
US6682917B1 (en) 2004-01-27
EP1191096A1 (de) 2002-03-27
US7256279B2 (en) 2007-08-14
EP1191096B1 (de) 2011-10-12
AU5569600A (en) 2001-01-31

Similar Documents

Publication Publication Date Title
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
BE2012C001I2 (de)
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
WO2003083041A3 (en) Cripto-specific antibodies
WO2000078344A8 (en) Prion protein peptides and uses thereof
SE9802729D0 (sv) Novel Compounds
WO2003087138A3 (en) Methods for identifying polypeptide factors interacting with rna
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
WO2004081229A3 (en) Use of bv8 and/or eg-vegf to promote hematopoiesis
WO2003020892A3 (en) Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
ATE528392T1 (de) Neues protein und dessen dns
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
ATE494307T1 (de) Neoplasma-spezifische antikörper und deren verwendungen
WO2002062964A3 (en) Ap1 amine oxidase variants
NZ514691A (en) Method to type prion proteins
DE60227078D1 (de) Allylmercaptocaptoprilverbindungen und deren verwendungen
ATE364180T1 (de) Screeningverfahren mit bnpi und dnpi
WO2005003289A3 (en) Ap1 amine oxidase variants
ATE490981T1 (de) Criptospezifische antikörper
TW200635953A (en) Specific binding agents of human angiopoietin-2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1191096

Country of ref document: EP